Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations

Alimentary Pharmacology & Therapeutics
M Lazzaroni, G Bianchi Porro

Abstract

Although adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) occur in only a small proportion of users, the widespread use of these drugs has resulted in a substantial overall number of affected persons who experience serious gastrointestinal complications. Dyspeptic symptoms are estimated to occur in 10-60% of NSAID users and lead to discontinuation of treatment in 5-15% of rheumatoid arthritis patients taking NSAIDs. It is now well established that the point prevalence of peptic ulcer disease in patients receiving conventional NSAID therapy ranges between 10 and 30%, representing a 10-30-fold increase over that found in the general population. One of 175 users of conventional NSAIDs in the USA will be hospitalized each year for NSAID-induced gastrointestinal damage. The mortality of hospitalized patients remains about 5-10%, with an expected annual death rate of 0.08%. The selective COX-II inhibitors (rofecoxib, celecoxib, parecoxib, etoricoxib, valdecoxib, lumiracoxib) show consistently comparable efficacy to that of conventional non-steroidal anti-inflammatory drugs (NSAIDs) in patients with rheumatoid arthritis and osteoarthritis, but have a significantly reduced propensity to cause gastrointestinal toxicity....Continue Reading

References

Dec 1, 1991·Clinical Rheumatology·H Zeidler
May 1, 1991·Annals of Internal Medicine·J M PiperM R Griffin
Sep 1, 1990·The American Journal of Physiology·P EggenaA Buku
Aug 26, 1998·British Journal of Rheumatology·M A IñiguezJ J Gomez-Reino
Jun 17, 1999·The New England Journal of Medicine·M M WolfeG Singh
Oct 27, 1999·Cleveland Clinic Journal of Medicine·B I Hirschowitz
Aug 10, 2000·Gastroenterology·C J Hawkey
Oct 12, 2000·The Medical Clinics of North America·C C Tseng, M M Wolfe
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Jan 3, 2001·The Journal of Clinical Investigation·P P Tak, G S Firestein
Apr 27, 2001·Trends in Immunology·S Fiorucci
Jul 24, 2001·Drugs·S M Cheer, K L Goa
Sep 21, 2001·Alimentary Pharmacology & Therapeutics·C J HawkeyUNKNOWN Rofecoxib Osteoarthritis Endoscopy Multinational Study Group
Jan 26, 2002·The American Journal of Gastroenterology·Randall R StoltzRichard C Hubbard
Feb 6, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·S FiorucciA Morelli
Mar 23, 2002·The American Journal of Cardiology·Claire Bombardier
May 1, 2002·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Richard H HuntJ Scott Whittaker
May 2, 2002·Journal of Gastroenterology and Hepatology·John G McHutchison
May 7, 2002·Journal of Pain and Symptom Management·Loren Laine
Jun 1, 2002·BMJ : British Medical Journal·Peter JüniPaul A Dieppe
Sep 25, 2002·Drugs·Douglas OrmrodAntona J Wagstaff
Oct 4, 2002·European Journal of Gastroenterology & Hepatology·David H SikesKenneth M Verburg
Feb 4, 2003·Alimentary Pharmacology & Therapeutics·R MicklewrightN Maskrey

❮ Previous
Next ❯

Citations

Oct 15, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Matteo FornaiMario Del Tacca
Jun 3, 2006·Clinical Rheumatology·Richard M Langford
Nov 16, 2013·Journal of Photochemistry and Photobiology. B, Biology·S R BarrettoL R Bonjardim
May 17, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·M SpychalskiA Dziki
Jul 6, 2007·BMC Gastroenterology·Michael LoydPhilip Jacobs
May 14, 2009·Therapeutics and Clinical Risk Management·Edward J Frech, Mae F Go
Apr 18, 2012·World Journal of Gastroenterology : WJG·Duangporn Thong-NgamNaruemon Klaikeaw
Jan 19, 2012·Oman Medical Journal·Abdulwahed Al-Saeed
May 28, 2005·Current Rheumatology Reports·Lee S Simon, Vibeke Strand
Nov 2, 2006·Current Medical Research and Opinion·Alfonso E Bello, Steffen Oesser
Sep 10, 2015·Journal of Pediatric Endocrinology & Metabolism : JPEM·Beata MałachowskaWojciech Młynarski
Jun 24, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·G A BonaterraR Kinscherf
Aug 30, 2008·Pharmacology, Biochemistry, and Behavior·Leonardo Rigoldi BonjardimMaria Cecília Ferraz de Arruda Veiga
Apr 27, 2007·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M LazzaroniG Bianchi Porro
Mar 21, 2006·Gastrointestinal Endoscopy Clinics of North America·Mae F Go
May 11, 2005·Scandinavian Journal of Immunology·A MirshafieyM Sotoude
Dec 14, 2011·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Cynthia H Fantini PaganiGert-Peter Brüggemann
Apr 15, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anna PawełczykLucjusz Zaprutko
Aug 11, 2005·Nutrition and Cancer·Harri MäkivuokkoNina Rautonen
Dec 13, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sahil KumarT R Bhardwaj
Jun 24, 2017·Pharmacology & Therapeutics·Karen M WagnerBruce D Hammock
Feb 21, 2018·Spine·Elizabeth M BadleyAnthony V Perruccio
Jul 5, 2006·The American Journal of Gastroenterology·Jaroslaw RegulaRenate Fischer
Nov 17, 2005·Rheumatology·S C MastbergenF P Lafeber
Jan 7, 2015·World Journal of Gastroenterology : WJG·Duangporn WerawatganonRungsun Rerknimitr
Dec 5, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jane A MitchellTimothy D Warner
Jun 10, 2020·Immunopharmacology and Immunotoxicology·Haitao WangXiaodong Yang
Apr 13, 2012·Experimental Biology and Medicine·Wei-Ping ChenLi-Dong Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.